Hypoxia-Inducible Factors, Stem Cells, and Cancer

Cell

Volumn 129, Issue 3, 2007, Pages 465-472

  Keith, Brian ^a,b   Simon, M Celeste ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR;

ANGIOGENESIS; CANCER STEM CELL; CELL DIVISION; CELL FUNCTION; CELL HYPOXIA; CELL METABOLISM; CELL RENEWAL; CELL TRANSFORMATION; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION INITIATION; TUMOR GROWTH;

EID: 34247527730     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2007.04.019     Document Type: Review

References (56)

1. Axelson H., Fredlund E., Ovenberger M., Landberg G., and Pahlman S. Hypoxia-induced dedifferentiation of tumor cells-a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin. Cell Dev. Biol. 16 (2005) 554-563
2. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7 (2006) 678-689
3. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
4. Cipolleschi M.G., Dello Sbarba P., and Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82 (1993) 2031-2037
5. Comerford K.M., Wallace T.J., Karhausen J., Louis N.A., Montalto M.C., and Colgan S.P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62 (2002) 3387-3394
6. Covello K.L., Kehler J., Yu H., Gordan J.D., Arsham A.M., Hu C.J., Labosky P.A., Simon M.C., and Keith B. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 20 (2006) 557-570
7. Cowden Dahl K.D., Fryer B.H., Mack F.A., Compernolle V., Maltepe E., Adelman D.M., Carmeliet P., and Simon M.C. Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation. Mol. Cell. Biol. 25 (2005) 10479-10491
8. Danet G.H., Pan Y., Luongo J.L., Bonnet D.A., and Simon M.C. Expansion of human SCID-repopulating cells under hypoxic conditions. J. Clin. Invest. 112 (2003) 126-135
9. Fuchs E. Scratching the surface of skin development. Nature 445 (2007) 834-842
10. Genbacev O., Zhou Y., Ludlow J.W., and Fisher S.J. Regulation of human placental development by oxygen tension. Science 277 (1997) 1669-1672
11. Gidekel S., Pizov G., Bergman Y., and Pikarsky E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4 (2003) 361-370
12. Gordan J.D., Bertout J.A., Hu C.J., Diehl A., and Simon M.C. HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity. Cancer Cell 11 (2007) 335-347
13. Gustafsson M.V., Zheng X., Pereira T., Gradin K., Jin S., Lundkvist J., Ruas J.L., Poellinger L., Lendahl U., and Bondesson M. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell 9 (2005) 617-628
14. Hochedlinger K., Yamada Y., Beard C., and Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121 (2005) 465-477
15. Huntly B.J., and Gilliland D.G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat. Rev. Cancer 5 (2005) 311-321
16. Joseph N.M., and Morrison S.J. Toward an understanding of the physiological function of Mammalian stem cells. Dev. Cell 9 (2005) 173-183
17. Kaidi A., Williams A.C., and Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol. 9 (2007) 210-217
18. Kehler J., Tolkunova E., Koschorz B., Pesce M., Gentile L., Boiani M., Lomeli H., Nagy A., McLaughlin K.J., Scholer H.R., and Tomilin A. Oct4 is required for primordial germ cell survival. EMBO Rep. 5 (2004) 1078-1083
19. Khatua S., Peterson K.M., Brown K.M., Lawlor C., Santi M.R., LaFleur B., Dressman D., Stephan D.A., and MacDonald T.J. Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res. 63 (2003) 1865-1870
20. Kiel M.J., Yilmaz O.H., Iwashita T., Yilmaz O.H., Terhorst C., and Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121 (2005) 1109-1121
21. Koshiji M., Kageyama Y., Pete E.A., Horikawa I., Barrett J.C., and Huang L.E. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 23 (2004) 1949-1956
22. Krishnamurthy P., Ross D.D., Nakanishi T., Bailey-Dell K., Zhou S., Mercer K.E., Sarkadi B., Sorrentino B.P., and Schuetz J.D. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem. 279 (2004) 24218-24225
23. Krivtsov A.V., Twomey D., Feng Z., Stubbs M.C., Wang Y., Faber J., Levine J.E., Wang J., Hahn W.C., Gilliland D.G., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442 (2006) 818-822
24. Lee T.I., Jenner R.G., Boyer L.A., Guenther M.G., Levine S.S., Kumar R.M., Chevalier B., Johnstone S.E., Cole M.F., Isono K., et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125 (2006) 301-313
25. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., Bourque G., George J., Leong B., Liu J., et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38 (2006) 431-440
26. Mancini S.J., Mantei N., Dumortier A., Suter U., MacDonald H.R., and Radtke F. Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation. Blood 105 (2005) 2340-2342
27. Maxwell P.H., Dachs G.U., Gleadle J.M., Nicholls L.G., Harris A.L., Stratford I.J., Hankinson O., Pugh C.W., and Ratcliffe P.J. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 94 (1997) 8104-8109
28. McMahon S., Charbonneau M., Grandmont S., Richard D.E., and Dubois C.M. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J. Biol. Chem. 281 (2006) 24171-24181
29. Merkle F.T., and Alvarez-Buylla A. Neural stem cells in mammalian development. Curr. Opin. Cell Biol. 18 (2006) 704-709
30. Michor F., Hughes T.P., Iwasa Y., Branford S., Shah N.P., Sawyers C.L., and Nowak M.A. Dynamics of chronic myeloid leukaemia. Nature 435 (2005) 1267-1270
31. Morrison S.J., and Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441 (2006) 1068-1074
32. Morrison S.J., Csete M., Groves A.K., Melega W., Wold B., and Anderson D.J. Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J. Neurosci. 20 (2000) 7370-7376
33. Morrison S.J., Perez S.E., Qiao Z., Verdi J.M., Hicks C., Weinmaster G., and Anderson D.J. Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell 101 (2000) 499-510
34. Nishi H., Nakada T., Kyo S., Inoue M., Shay J.W., and Isaka K. Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol. Cell. Biol. 24 (2004) 6076-6083
35. Niwa H., Miyazaki J., and Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24 (2000) 372-376
36. Ohlstein B., and Spradling A. The adult Drosophila posterior midgut is maintained by pluripotent stem cells. Nature 439 (2006) 470-474
37. Ohlstein B., Kai T., Decotto E., and Spradling A. The stem cell niche: theme and variations. Curr. Opin. Cell Biol. 16 (2004) 693-699
38. Pear W.S., and Aster J.C. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr. Opin. Hematol. 11 (2004) 426-433
39. Pouyssegur J., Dayan F., and Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 (2006) 437-443
40. Ramirez-Bergeron D.L., and Simon M.C. Hypoxia-inducible factor and the development of stem cells of the cardiovascular system. Stem Cells 19 (2001) 279-286
41. Raval R.R., Lau K.W., Tran M.G., Sowter H.M., Mandriota S.J., Li J.L., Pugh C.W., Maxwell P.H., Harris A.L., and Ratcliffe P.J. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol. Cell. Biol. 25 (2005) 5675-5686
42. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
43. Ryan H.E., Poloni M., McNulty W., Elson D., Gassmann M., Arbeit J.M., and Johnson R.S. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 60 (2000) 4010-4015
44. Sancho E., Batlle E., and Clevers H. Signaling pathways in intestinal development and cancer. Annu. Rev. Cell Dev. Biol. 20 (2004) 695-723
45. Schipani E., Ryan H.E., Didrickson S., Kobayashi T., Knight M., and Johnson R.S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 15 (2001) 2865-2876
46. Seagroves T., and Johnson R.S. Two HIFs may be better than one. Cancer Cell 1 (2002) 211-213
47. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
48. Seydoux G., and Braun R.E. Pathway to totipotency: lessons from germ cells. Cell 27 (2006) 891-904
49. Studer L., Csete M., Lee S.H., Kabbani N., Walikonis J., Wold B., and McKay R. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J. Neurosci. 20 (2000) 7377-7383
50. Tai M.H., Chang C.C., Kiupel M., Webster J.D., Olson L.K., and Trosko J.E. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26 (2005) 495-502
51. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
52. Vescovi A.L., Galli R., and Reynolds B.A. Brain tumour stem cells. Nat. Rev. Cancer 6 (2006) 425-436
53. Weng A.P., and Aster J.C. Multiple niches for Notch in cancer: context is everything. Curr. Opin. Genet. Dev. 14 (2004) 48-54
54. Weng A.P., Millholland J.M., Yashiro-Ohtani Y., Arcangeli M.L., Lau A., Wai C., Del Bianco C., Rodriguez C.G., Sai H., Tobias J., et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 20 (2006) 2096-2109
55. Wiesener M.S., Jurgensen J.S., Rosenberger C., Scholze C.K., Horstrup J.H., Warnecke C., Mandriota S., Bechmann I., Frei U.A., Pugh C.W., et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J. 17 (2003) 271-273
56. Wilson A., and Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett. 580 (2006) 2860-2868